Cargando…
Sirolimus Therapy and Follow-up in a Patient with Severe Congenital Hyperinsulinism Following Subtotal Pancreatectomy
Congenital hyperinsulinism (CHI) is the most common cause of severe, persistent hypoglycemia in neonates and infants. If the patient does not respond to medical treatment the currently available treatment is subtotal pancreatectomy, but some patients still experience severe hypoglycemia after surger...
Autores principales: | Chen, Qiong, Chen, Yongxing, Wang, Xiaohong, Yang, Haihua, Zhang, Yingxian, Liu, Xiaojing, Yan, Yun, Wei, Haiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947726/ https://www.ncbi.nlm.nih.gov/pubmed/32482020 http://dx.doi.org/10.4274/jcrpe.galenos.2020.2020.0033 |
Ejemplares similares
-
Sirolimus treatment of severe congenital hyperinsulinism
por: Amato, Lisa A, et al.
Publicado: (2015) -
Sirolimus therapy following subtotal pancreatectomy in neonatal hyperinsulinemic hypoglycaemia: a case report
por: Abraham, Mary, et al.
Publicado: (2015) -
Clinical Efficacy Evaluation of Sirolimus in Congenital Hyperinsulinism
por: Hashemian, Somayyeh, et al.
Publicado: (2020) -
Successful treatment of a newborn with congenital hyperinsulinism having a novel heterozygous mutation in the ABCC8 gene using subtotal pancreatectomy
por: Yen, Chi-Feng, et al.
Publicado: (2016) -
Pancreatic Endocrine and Exocrine Function in Children following Near-Total Pancreatectomy for Diffuse Congenital Hyperinsulinism
por: Arya, Ved Bhushan, et al.
Publicado: (2014)